tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALKS Stock Latest News

Alkermes Advances ALKS 2680 Into Phase 3 for Narcolepsy Type 1: What Investors Should Watch
Company AnnouncementsAlkermes Advances ALKS 2680 Into Phase 3 for Narcolepsy Type 1: What Investors Should Watch
17d ago
ALKS
Alkermes’ ALKS 2680 Narcolepsy Study Completion: What Investors Should Watch Next
PremiumCompany Announcements
Alkermes’ ALKS 2680 Narcolepsy Study Completion: What Investors Should Watch Next
24d ago
ALKS
Alkermes price target lowered to $43 from $46 at H.C. Wainwright
PremiumThe Fly
Alkermes price target lowered to $43 from $46 at H.C. Wainwright
25d ago
ALKS
Balanced Risk-Reward Amid Softer 2026 Outlook Keeps Rating at Hold
PremiumRatings
Balanced Risk-Reward Amid Softer 2026 Outlook Keeps Rating at Hold
26d ago
ALKS
Alkermes Earnings Call: Growth, LUMRIZE and New Risks
PremiumCompany Announcements
Alkermes Earnings Call: Growth, LUMRIZE and New Risks
26d ago
ALKS
Alkermes: Durable Commercial Portfolio, Alixorexton Catalyst, and Orderly CEO Transition Support Buy Rating
PremiumRatingsAlkermes: Durable Commercial Portfolio, Alixorexton Catalyst, and Orderly CEO Transition Support Buy Rating
26d ago
ALKS
Alkermes Announces CEO Succession and Leadership Transition Plan
Premium
Company Announcements
Alkermes Announces CEO Succession and Leadership Transition Plan
26d ago
8K
ALKS
Alkermes reports Q4 GAAP EPS 29c, consensus 45c
Premium
The Fly
Alkermes reports Q4 GAAP EPS 29c, consensus 45c
26d ago
ALKS
Alkermes sees FY26 revenue $1.73B-$1.84B, consensus $1.83B
PremiumThe Fly
Alkermes sees FY26 revenue $1.73B-$1.84B, consensus $1.83B
26d ago
ALKS
Alkermes CEO Richard Pops to retire, Blair Jackson to succeed
PremiumThe Fly
Alkermes CEO Richard Pops to retire, Blair Jackson to succeed
26d ago
ALKS
Alkermes initiated with an Outperform at Wolfe Research
PremiumThe Fly
Alkermes initiated with an Outperform at Wolfe Research
28d ago
ALKS
Alkermes price target raised to $34 from $33 at BofA
PremiumThe Fly
Alkermes price target raised to $34 from $33 at BofA
1M ago
ALKS
Alkermes Completes Avadel Acquisition, Expands Sleep Medicine Portfolio
PremiumCompany AnnouncementsAlkermes Completes Avadel Acquisition, Expands Sleep Medicine Portfolio
1M ago
8K
ALKS
Irish High Court sanctions Avadel Pharmaceuticals acquisition by Alkermes
Premium
The Fly
Irish High Court sanctions Avadel Pharmaceuticals acquisition by Alkermes
1M ago
ALKS
AVDL
ALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ALKS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
ALKS
3 Best Value Stocks with Over 20% Upside in 2026, According to Analysts 
PremiumMarket News
3 Best Value Stocks with Over 20% Upside in 2026, According to Analysts 
2M ago
LKQ
UAL
Avadel Pharmaceuticals shareholders approve acquisition by Alkermes
PremiumThe Fly
Avadel Pharmaceuticals shareholders approve acquisition by Alkermes
2M ago
ALKS
AVDL
Alkermes plans Avadel acquisition to expand sleep portfolio
PremiumCompany Announcements
Alkermes plans Avadel acquisition to expand sleep portfolio
2M ago
8K
ALKS
Alkermes jumps 3% after FDA grants alixorexton breakthrough designation
PremiumThe Fly
Alkermes jumps 3% after FDA grants alixorexton breakthrough designation
3M ago
ALKS
Alkermes Gains FDA Breakthrough Status for Narcolepsy Drug
PremiumCompany AnnouncementsAlkermes Gains FDA Breakthrough Status for Narcolepsy Drug
3M ago
8K
ALKS
Alkermes granted Breakthrough Therapy designation for alixorexton by FDA
Premium
The Fly
Alkermes granted Breakthrough Therapy designation for alixorexton by FDA
3M ago
ALKS
Centessa price target raised to $42 from $33 at B. Riley
Premium
The Fly
Centessa price target raised to $42 from $33 at B. Riley
4M ago
ALKS
CNTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >